GridAI Technologies GRDX
NASDAQ GRDX
$3.57 -0.18 (-4.83%)
As of: Aug 21, 2026 · 3:59 PM EDT

GridAI Technologies (GRDX) Liabilities from Discontinued Operations (2024 - 2025)

GridAI Technologies' (GRDX) quarterly Liabilities from Discontinued Operations came in at 23672708.0 in Q3 2025, up 98.63% YoY from 11918261.0 in Q3 2024, and up 0.54% on a QoQ basis from 23546478.0 in Q2 2025.

GridAI Technologies (GRDX) Liabilities from Discontinued Operations (2024 - 2025) Analysis & Trends

GridAI Technologies (GRDX) has 2 years of Liabilities from Discontinued Operations data on file, last reported at 23672708.0 in Q3 2025.

  • Quarterly Liabilities from Discontinued Operations rose 98.63% year-over-year to 23672708.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 23672708.0 (up 98.63% YoY) and the FY2024 annual result came in at 22941497.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations advanced to 23672708.0 in Q3 2025, from 23546478.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 23672708.0 in Q3 2025 to a low of 10110414.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 GridAI Technologies 5.82 Mn 5.82 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 23.67 Mn
Sep 30, 2025 23.67 Mn
Jun 30, 2025 23.55 Mn
Jun 30, 2025 23.55 Mn
Mar 31, 2025 23.22 Mn
Mar 31, 2025 23.22 Mn
Dec 31, 2024 22.94 Mn
Dec 31, 2024 22.94 Mn
Sep 30, 2024 11.92 Mn
Sep 30, 2024 11.92 Mn
Jun 30, 2024 10.11 Mn
Jun 30, 2024 10.11 Mn